Home › Funds › SOUND SHORE MANAGEMENT INC /CT/ › REGN
SOUND SHORE MANAGEMENT INC /CT/ position in REGN
REGENERON PHARMACEUTICALS · Health Care
SOUND SHORE MANAGEMENT INC /CT/ reported holding 126,179 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$95.7M, representing 2.99% of its reported portfolio and ranking #6 among its reported holdings. SOUND SHORE MANAGEMENT INC /CT/ has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SOUND SHORE MANAGEMENT INC /CT/'s REGN position evolved
SOUND SHORE MANAGEMENT INC /CT/ first disclosed a stake in REGN in Q3 2025 at 115,028 shares (US$64.7M). The position peaked in Q4 2025 at 175,887 shares, worth US$135.8M. Across 5 filings, SOUND SHORE MANAGEMENT INC /CT/ increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 126,179 shares valued at US$95.7M — a reduction of -815 shares quarter over quarter.. Notable position changes include a 53% increase in Q4 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 115.03K | $64.68M | New |
| Q4 2025 | 175.89K | $135.76M | Add |
| Q1 2026 | 150.96K | $116.64M | Reduce |
| Q2 2026 | 126.99K | $79.19M | Reduce |
| Q3 2026 | 126.18K | $95.68M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on SOUND SHORE MANAGEMENT INC /CT/
FAQ
How long has SOUND SHORE MANAGEMENT INC /CT/ held REGN?
SOUND SHORE MANAGEMENT INC /CT/ has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is SOUND SHORE MANAGEMENT INC /CT/'s current position in REGN?
As of Q3 2026, SOUND SHORE MANAGEMENT INC /CT/ holds 126.18K shares of REGN (REGENERON PHARMACEUTICALS), valued at $95.68M, representing 2.99% of its reported portfolio and ranking #6.
Has SOUND SHORE MANAGEMENT INC /CT/ been buying or selling REGN?
In the latest 13F filing (Q3 2026), SOUND SHORE MANAGEMENT INC /CT/ reduced its position in REGN. The position peaked in Q4 2025 at 175.89K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.